Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **skin surface/protective barrier** is a multifactorial system comprised mainly of the **stratum corneum**, the outermost layer of the epidermis. It consists of flattened, dead corneocytes bound by specialized proteins (e.g., filaggrin, involucrin, loricrin) and lipids (mainly ceramides, cholesterol, free fatty acids), organized into a "brick and mortar" structure[2][3][5][6]. This physical barrier prevents water loss, blocks entry of pathogens and toxins, and supports immune surveillance. Key chemical elements such as the acid mantle and antimicrobial peptides further defend against infection and help regulate pH. A healthy barrier is essential for skin hydration, resistance to irritation, and overall skin health. Dysfunction leads to increased susceptibility to disease, including dermatitis and infection[2][4][9].
Restoration of lipid/protein composition, enhancement of hydration, reduction of inflammation, prevention of pathogenic penetration, acidification to promote homeostasis[3][6][9]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin barrier (or Stratum corneum for the main component).